Inflammation and pruritus in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 17, Issue 12, 2002, Pages 2164-2169

  Virga, Giovambattista ^a   Vicentin, Ivana ^a   La Milia, Vincenzo ^b   Bonadonna, Antonio ^a  

^a Provincial Hospital   (Italy)

^b Provincial Hospital Authority   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CREATININE; FERRITIN; GLUCOSE; IRON; PHOSPHORUS; PLASMA PROTEIN; SERUM ALBUMIN; TRANSFERRIN; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEGALOCYTOSIS; MICROCYTOSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; RETICULOCYTE; STATISTICAL SIGNIFICANCE; TRANSFERRIN BLOOD LEVEL; UREA BLOOD LEVEL; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; FEMALE; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; PRURITUS; RENAL DIALYSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 1842852810     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.12.2164     Document Type: Article

References (20)

1. Hiroshige K, Kabashima N, Takasugi M, Kuroiwa A. Optimal dialysis improves uremic pruritus. Am J Kidney Dis 1995; 25: 413-419
2. Massry SG, Popovtzer MM, Coburn JW, Makoff DL, Maxwell MH, Kleeman CR. Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia: disappearance of itching after subtotal parathyroidectomy. N Engl J Med 1968; 279: 697-700
3. Mamianetti A, Tripodi V, Vescina C et al. Serum bile acids and pruritus in hemodialysis patients. Clin Nephrol 2000; 53: 194-198
4. De Marchi S, Cecchin E, Villalta D, Sepiacci G, Santini G, Bartoli E. Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 1992; 326: 969-974
5. Robertson KE, Mueller BA. Uremic pruritus. Am J Health Syst Pharm 1996; 53: 2159-2170
6. Adams SJ. Iron deficiency, serum ferritin, generalised pruritus and systemic disease: a case control study. Br J Dermatol 1989; 121 [Suppl 34]: 15.
7. Daugirdas JT. The post/pre plasma urea nitrogen ratio to estimate Kt/V and NPC: mathematical modeling. Int J Artif Organs 1989; 12: 411-419
8. Sato S. Iron deficiency: structural and microchemical changes in hair, nails, and skin. Semin Dermatol 1991; 10: 313-319
9. Drüeke TB, Bárány P, Cazzola M et al. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol 1997; 48: 1-8
10. Bistrian B, Khaodhiar L. The systemic inflammatory response and its impact in iron nutriture in end-stage renal disease. Am J Kidney Dis 1999; 34 [Suppl 2]: S35-S39
11. Kaysen G, Stevenson F, Depner T. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29: 658-668
12. Schouten WE, Grooteman MP, van Houte AJ, Schoorl M, van Limbeek J, Nube MJ. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 2000; 15: 379-384
13. Yancey KB, Hammer CH, Harvath L, Renfer L, Frank MM, Lawley TJ. Studies of human C5a as a mediator of inflammation in normal human skin. J Clin Invest 1985; 75: 486-495
14. Wahlgren CF, Tengvall Linder M, Hagermark O, Scheynius A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995; 287: 572-580
15. Mettang T, Pauli-Magnus C. The pathophysiological puzzle of uremic pruritus-insight and speculations from therapeutic and epidemiological studies. Perit Dial Int 2000; 20: 493-494
16. Garssen J, Vandebriel RJ, de Gruijl FR et al. UVB exposure-induced systemic modulation of Th1 - and Th2-mediated immune responses. Immunology 1999; 97: 506-514
17. Gilchrest BA, Rowe JW, Brown RS, Steinman TI, Arndt KA. Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med 1979; 91: 17-21
18. McHugh SM, Rifkin IR, Deighton J et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen-and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995; 99: 160-167
19. Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, Lugon JR. Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 1994; 67: 270-273
20. Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflammation Research 1997; 46: 4-18